Maturation pathways of dendritic cells determine TAP1 and TAP2 levels and cross-presenting function.
about
Tumor antigen-specific monoclonal antibodies and induction of T-cell immunityTherapeutic cancer vaccines and combination immunotherapies involving vaccinationDendritic cells reveal a broad range of MHC class I epitopes for HIV-1 in persons with suppressed viral load on antiretroviral therapyPhase I dendritic cell p53 peptide vaccine for head and neck cancer.Nimotuzumab Induces NK Cell Activation, Cytotoxicity, Dendritic Cell Maturation and Expansion of EGFR-Specific T Cells in Head and Neck Cancer PatientsTumor antigen-targeted, monoclonal antibody-based immunotherapy: clinical response, cellular immunity, and immunoescape.IRX-2, a novel immunotherapeutic, enhances functions of human dendritic cells.STAT1-Induced HLA Class I Upregulation Enhances Immunogenicity and Clinical Response to Anti-EGFR mAb Cetuximab Therapy in HNC Patients.Immunotherapy of cancer in 2012.Cetuximab-activated natural killer and dendritic cells collaborate to trigger tumor antigen-specific T-cell immunity in head and neck cancer patientsImpact of the Type I Interferon Receptor on the Global Gene Expression Program During the Course of Dendritic Cell Maturation Induced by Polyinosinic Polycytidylic Acid.Effective Cytotoxic T Lymphocyte Targeting of Persistent HIV-1 during Antiretroviral Therapy Requires Priming of Naive CD8+ T CellsTLR3 agonists improve the immunostimulatory potential of cetuximab against EGFR(+) head and neck cancer cells.Intratumoral regulatory T cells upregulate immunosuppressive molecules in head and neck cancer patients.Polarized dendritic cells as cancer vaccines: directing effector-type T cells to tumors.Natural killer (NK): dendritic cell (DC) cross talk induced by therapeutic monoclonal antibody triggers tumor antigen-specific T cell immunity.HLA class II antigen-processing pathway in tumors: Molecular defects and clinical relevance.Dendritic cells in cancer immunotherapy: vaccines or autologous transplants?Targeted Therapies: Immunologic Effects and Potential Applications Outside of Cancer.CD137 Stimulation Enhances Cetuximab-Induced Natural Killer: Dendritic Cell Priming of Antitumor T-Cell Immunity in Patients with Head and Neck Cancer.Increased PD-1+ and TIM-3+ TILs during Cetuximab Therapy Inversely Correlate with Response in Head and Neck Cancer Patients.Ilixadencel - an Allogeneic Cell-Based Anticancer Immune Primer for Intratumoral Administration.
P2860
Q27009908-602DB4E0-42B2-4876-8BF2-0F5FBE6F3C6CQ28397609-26DA5E86-A060-4759-B512-648983538603Q28475576-28DC3E5B-1477-448F-AE86-AC76C73E5808Q30577847-8B0C4D66-F1BE-4F78-B14C-8192D1F5C05CQ33809528-02C41B93-3D04-4640-B82D-461D3F1F6422Q34194706-BD4FA198-4D3A-4B6C-942B-602B917E1DB1Q34585798-D8DE766C-8786-456E-991B-CC62305FDA00Q35920773-5939BCB9-0C74-4482-A204-B0BF4B4AFB04Q36243536-2E02B9FA-3995-490F-ADAC-5726523F7992Q36806268-E4E261DE-8225-4F61-9E53-E0ACE75DB052Q36966559-11D75DD3-3019-4224-9897-D2129AEB58DEQ36974205-68E31FBF-A065-4E3E-903F-37842A4174B2Q37028027-FB4A33E1-4BD5-44C5-BC90-54E65B2AAC94Q37323082-343475EA-07E3-4011-A65E-A7A8A2EDE00BQ37735454-925BA367-AE5E-41AD-B9F9-4BA94920D2CCQ37895956-36F684A6-88EF-46EF-92AB-F092E8260C86Q39201713-026BC5B9-2155-4B27-8096-BB9BB0B4D4CBQ41520681-EA44DA6C-DFF0-4A85-BBB6-49D06496E6F7Q47350013-C2AC3973-8390-43ED-83D5-B2A56D384F5FQ50043038-FF31747E-7BB8-4AE7-83C8-D15AEB4E6FE8Q52776942-847903AB-1E71-4237-8F48-E918636CDDE2Q55380684-FACC84DA-1F73-4507-85C0-4EF0A931DE89
P2860
Maturation pathways of dendritic cells determine TAP1 and TAP2 levels and cross-presenting function.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Maturation pathways of dendrit ...... and cross-presenting function.
@en
Maturation pathways of dendrit ...... and cross-presenting function.
@nl
type
label
Maturation pathways of dendrit ...... and cross-presenting function.
@en
Maturation pathways of dendrit ...... and cross-presenting function.
@nl
prefLabel
Maturation pathways of dendrit ...... and cross-presenting function.
@en
Maturation pathways of dendrit ...... and cross-presenting function.
@nl
P2093
P2860
P1476
Maturation pathways of dendrit ...... and cross-presenting function.
@en
P2093
Andrés López-Albaitero
Pawel Kalinski
Pedro A Andrade Filho
Robert L Ferris
Soldano Ferrone
Trevor Hackman
William Gooding
Xinhui Wang
P2860
P304
P356
10.1097/CJI.0B013E3181A1C24E
P577
2009-06-01T00:00:00Z